ロード中...
Effect of Chewing vs Swallowing Ticagrelor on Platelet Inhibition in Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial
IMPORTANCE: Dual anti-platelet therapy represents standard care for treating patients with ST-segment elevation myocardial infarction (STEMI). Ticagrelor is a direct-acting P2Y12 inhibitor and, unlike clopidogrel and prasugrel, does not require metabolic activation. OBJECTIVE: To evaluate whether ch...
保存先:
| 出版年: | JAMA Cardiol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Medical Association
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5814990/ https://ncbi.nlm.nih.gov/pubmed/29071332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2017.3868 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|